Clinical Trials Logo

Filter by:
NCT ID: NCT00804830 Terminated - Metastatic Cancer Clinical Trials

Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

Start date: April 2008
Phase: Phase 2
Study type: Interventional

Anaplastic Thyroid Cancer is a very aggressive disease. The investigators believe that angiogenesis is very important for these tumors to progress. Preclinical data is suggesting this. This is why we we prospectively want to treat these patients with avastin (and doxorubicin). However, local control is of major concern. Therefore, patients are initially treated with hyperfractionated radiotherapy and undergo surgery. Then they can enter this study.

NCT ID: NCT00804232 Recruiting - Diabetes, Type I Clinical Trials

Childhood Diabetes

Start date: January 2008
Phase: N/A
Study type: Interventional

Purpose of the study: To compare three different regimes for children newly diagnosed with type 1 diabetes: (1) traditional hospital based care, (2) intensive psychological support to the family, and (3) home based family psychosocial support. A further aim is to identify families were the child runs the risk of decreased metabolic control and to give those families increased support. Specific objectives: The main objectives of the study are: 1. to analyse the effects on child health of family-based home care compared to traditional hospital-based care, and 2. to analyse the effects on child health of family-based psychological treatment compared to traditional hospital-based treatment. The main focus will be on child health and changes in child health. Several variables will be collected for these purpose (see instruments, below), the main variable being the child's metabolic control. We will also analyse effects on the amount and content of (1) parental efforts (absenteeism from work; time use which is conditional on the child's diabetes etc), and (2) formal health care utilisation of the home-based care and psychological treatment, respectively, compared to traditional care.

NCT ID: NCT00803985 Completed - Chronic Pain Clinical Trials

Study Comparing Total Extraperitoneal Patch "TEP" Versus Lichtenstein According Chronic Pain

TEP-LICH
Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to se if there is a difference regarding chronic pain and sexual dysfunction one and tree years after laparoscopic un fixated preperitoneal mesh versus gold standard open fixated on lay mesh in inguinal hernia surgery. Long term cross-sectional follow-up comparing different instruments for measurement of chronic pain.

NCT ID: NCT00803855 Completed - Healthy Clinical Trials

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers

SAD
Start date: December 2008
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to assess the safety and tolerability of AZD1446 following single dose administration.

NCT ID: NCT00803491 Active, not recruiting - Rheumatic Diseases Clinical Trials

Health Related Quality of Life After a Self-promoting Learning Program for People With Rheumatic Diseases

Start date: December 2008
Phase: N/A
Study type: Interventional

Randomized controlled trial including 200 subjects with rheumatic diseases. Subjects will be randomized to either a self-promoting problem based learning (PBL) program or a control group with traditional care. The hypothesis is that a PBL program will improve health-related quality of life, empowerment and self-care ability.

NCT ID: NCT00803205 Completed - Cystic Fibrosis Clinical Trials

Study of Ataluren (PTC124™) in Cystic Fibrosis

Start date: September 8, 2009
Phase: Phase 3
Study type: Interventional

Cystic fibrosis (CF) is a genetic disorder caused by a mutation in the gene that makes the cystic fibrosis transmembrane conductance regulator (CFTR) protein. A specific type of mutation called a nonsense (premature stop codon) mutation is the cause of CF in approximately 10% of patients with the disease. Ataluren is an orally delivered investigational drug that has the potential to overcome the effects of the nonsense mutation. This study is a Phase 3 trial that will evaluate the clinical benefit of ataluren in adult and pediatric participants with CF due to a nonsense mutation. The main goals of the study are to understand whether ataluren can improve pulmonary function and whether the drug can safely be given for a long period of time. The study will also assess the effects of ataluren on CF pulmonary exacerbation frequency, cough frequency, health-related quality of life, antibiotic use for CF-related infections, CF-related disruptions to daily living, body weight, and CF pathophysiology.

NCT ID: NCT00803049 Completed - Multiple Sclerosis Clinical Trials

Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to document the long-term safety and tolerability of teriflunomide in Multiple Sclerosis (MS) patients with relapse. The secondary objective is to document the long-term efficacy on disability progression, relapse rate and Magnetic Resonance Imaging (MRI) parameters.

NCT ID: NCT00802750 Completed - Catheterization Clinical Trials

Study Where Healthy Volunteers Evaluate LoFric Catheters

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate healthy volunteers perception of catheterization with LoFric catheters with new solvents in the manufacturing process. The subjects will be catheterized three times during one visit day. The hypothesis is that the subjects' perception of catheterization is the same when using the test catheters compared to the reference catheter.

NCT ID: NCT00802737 Completed - Clinical trials for Leukaemia, Lymphocytic, Chronic

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Start date: January 2009
Phase: Phase 4
Study type: Interventional

The purpose of the trial is to investigate the efficacy and safety of ofatumumab retreatment and maintenance in patients with chronic lymphocytic leukemia who have previously responded or had disease stabilization after ofatumumab in an ongoing trial (Hx-CD20-406).

NCT ID: NCT00802373 Completed - Clinical trials for Urinary Bladder, Overactive

Solifenacin Succinate Versus Tolterodine 4mg Once Daily

STAR
Start date: July 2003
Phase: Phase 3
Study type: Interventional

Prospective, double-blind, double-dummy, 2-arm, parallel-group, design. Flexible dose regimen for solifenacin succinate, fixed dose treatment regimen for tolterodine. Assessment of OAB symptoms by patient diaries.